Despite significant progress in understanding the molecular mechanism of NUP98 fusions and their concomitant genetic alterations in oncogenesis, finding effective therapeutic strategies for this AML subtype is still a significant challenge. Here, NUP98 is linked to acute myeloid leukemia.